During the past decade, Valley Health System-Hematology/Oncology conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 13 clinical trials were completed, i.e. on average, 48.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 11 clinical trials were completed. i.e. 110% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Valley Health System-Hematology/Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 20 trials, followed by "SWOG Cancer Research Network" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "GOG Foundation" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Valley Health System-Hematology/Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Valley Health System-Hematology/Oncology" are "Recurrent Squamous Cell Lung Carcinoma" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Invasive Breast Carcinoma" (3 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials) and "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Valley Health System-Hematology/Oncology" in a lesser frequency.

Most popular intervention types in "Valley Health System-Hematology/Oncology" are "Drug" (32 trials), "Other" (26 trials), "Biological" (20 trials), "Procedure" (10 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (14 trials), "Laboratory Biomarker Analysis" (13 trials), "Computed Tomography" (8 trials), "Cisplatin" (7 trials) and "Biospecimen Collection" (6 trials). Other intervention names were less common.

The vast majority of trials in "Valley Health System-Hematology/Oncology" are 30 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Valley Health System-Hematology/Oncology". undefined are not yet recruiting, 7 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Valley Health System-Hematology/Oncology, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Valley Health System-Hematology/Oncology, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".